PLATINUM2024

Augies Quest To Cure ALS Inc

Incurable is Unacceptable

Denver, CO   |  https://augiesquest.org

Mission

Founded by Augie Nieto, Augie's Quest is the unwavering force driving breakthroughs in ALS research, defying limitations, and empowering hope for a future without this devastating disease. Augie’s Quest has been working with ALS-TDI, the world's foremost drug discovery lab focused solely on ALS, since 2006 to bring new treatments and ultimately a cure to those with ALS. Whereas many ALS organizations are focused on everyday support for those living with ALS, Augie’s Quest is committed to the greater goal of ending the disease for good.

Ruling year info

2018

Chairman of the Board

Lynne Nieto

Main address

PO Box 9886

Denver, CO 80209 USA

Show more contact info

EIN

83-0934624

NTEE code info

Fund Raising and/or Fund Distribution (H12)

IRS filing requirement

This organization is required to file an IRS Form 990 or 990-EZ.

Sign in or create an account to view Form(s) 990 for 2022, 2021 and 2020.
Register now

Communication

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

There is no effective cure for Amyotrophic Lateral Sclerosis. We work to fill the funding gap to fund the best science to fund treatments and eventually a cure for ALS. Augie’s Quest to Cure ALS is dedicated to changing the experience of people living with ALS. We raise the funds and awareness urgently needed to advance cutting-edge research, fast-track effective treatments, and ultimately, find a cure for this devastating disease.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Augie's Quest Translational Research Center at ALS TDI

The Augie’s Quest Translational Research Center will help to strengthen existing and future research efforts at the ALS Therapy Development Institute by aiming to dissect mechanisms of clinical ALS and use the knowledge to develop new, more powerful drug discovery platforms and facilitate more effective drug development in ALS.

Population(s) Served
People with diseases and illnesses
Families

Augie's Quest has committed to a $4 million grant to advance a new lead drug candidate through an IND application submission to arrive at a drug product that can be tested in human Phase 1 clinical safety testing, then in Phase 2 trials for human ALS efficacy assessment at the ALS Therapy Development Institute. Work will include Copper Complex:
-Lead Identification and Optimization:
-Non-GLP In Vitro and Mouse Toxicity and Tolerability Studies
-Non-GLP Rat PK, Toxicity and Tolerability Studies
-Non-GLP Rat PK, Toxicity and Tolerability Studies
-Large Animal PK, Toxicity and Tolerability Studies
-Environmental Safety Assessment
-Formulations Development
-Bulk Drug Manufacturing Method Development
-Bulk Drug Batch Manufacture, Release, and Formulations
-FDA Investigational New Drug Application Submission

Population(s) Served
People with diseases and illnesses
People with disabilities

Where we work

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Total dollar amount of grants awarded

This metric is no longer tracked.
Totals By Year
Population(s) Served

People with physical disabilities, Terminally ill people

Related Program

Augie's Quest Translational Research Center at ALS TDI

Type of Metric

Output - describing our activities and reach

Direction of Success

Holding steady

Context Notes

These metrics are in millions. 2023:$2,654,066 2022: $2,926,024 2021: $3,160,785 2020: $2,700,000 2019: $3,652,633

Number of donations received for ALS Research

This metric is no longer tracked.
Totals By Year
Population(s) Served

People with diseases and illnesses

Related Program

Augie's Quest Translational Research Center at ALS TDI

Type of Metric

Outcome - describing the effects on people or issues

Direction of Success

Increasing

Context Notes

Many 2019 fitness industry campaigns were not able to repeat in 2020 and 2021 due to pandemic closures, so the number of gifts was lower. The number of non-fitness donations increased.

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

We know ALS is a disease we can tackle, a problem we can solve. Because ALS is curable; it’s just underfunded. There are many needs in the ALS community, so we are singularly focused on funding translational research.

Our goal is to fund translational research that will most efficiently and effectively result in treatments for ALS. In order to do this, we will fund grants to research organizations. Our grants are milestone driven and require the research institution to spend the money directly on research (versus bricks and mortar, marketing, or overhead).

Augie’s Quest to Cure ALS raises the funds and awareness urgently needed to advance cutting-edge research, fast-track effective treatments, and ultimately, find a cure for ALS. This is done through funding the best research with the highest probability of helping families currently living with the disease.

In order to fund the right research, we must raise the money needed. Our strong Board of Directors, Leadership and Fitness Advisory Council's work with our team to create fundraising platforms that make it easy and impactful for individuals to donate to the Quest. We coordinate best in class fundraising cause campaigns, successful Gala's, and in-club fitness activations to raise money to fuel the cure.

These dollars are granted to credible research organizations that meet designated milestones with peer-review papers.

Augie's Quest to Cure ALS has experience raising the funds necessary to fund the best ALS research. Prior to becoming our own 501c3 in 2018, we'd raised almost $150 million for ALS research. Our leadership is experienced in this, and the numbers show the efficiency and ability to make it happen.

The Augie’s Quest Translational Research Center at ALS TDI honors the work, innovation and steadfast support of Augie’s Quest and its many generous and committed donors to finding a cure for ALS. Housed within ALS TDI’s Cambridge, Mass., laboratory, the Augie’s Quest Translational Research Center will help to strengthen its existing and future research efforts by aiming to dissect mechanisms of clinical ALS and use the knowledge to develop new, more powerful drug discovery platforms and facilitate more effective drug development in ALS.

• December 2021: Augie’s Quest to Cure ALS announced a $5.8 million commitment to fund the discovery of new candidate drugs to slow, stop, or even reverse ALS disease progression at the Augie’s Quest Translational Research Center through 2024. These funds will cover science staff compensation, yearly equipment costs, and additional needs at the Augie’s Quest Translational Research Center, a key component of the ALS TDI Drug Discovery Engine.

• August 2021: Augie’s Quest to Cure ALS provided $125,000 to the ALS Therapy Development Institute in honor of Phil Green so scientists at the Augie’s Quest Translational Research Center can develop the next generation human induced pluripotent stem cell models to discover key biological features that distinguish subtypes of ALS with the goal of making each of those subtypes treatable.

o January 2020: the ALS Therapy Development Institute announced the creating of the Augie’s Quest Translational Research Center at ALS TDI. This Research Center honors the work, innovation and steadfast support of Augie’s Quest and its many generous and committed donors to finding a cure for ALS. Housed within ALS TDI’s laboratory, the Augie’s Quest Translational Research Center will help to strengthen its existing and future research efforts by aiming to dissect mechanisms of clinical ALS and use the knowledge to develop new, more powerful drug discovery platforms and facilitate more effective drug development in ALS.

2. Discovery Biology Suite at ALS TDI dedicated in honor of Elizabeth Scott Bodine - changing outcomes for people living with ALS

• December 2021 $1.5 million was granted to ALS TDI in 2021 for the discovery of new drug targets, or intervention points, for the effective treatment of ALS. The discovery of a new drug target for ALS is akin to opening an entirely new avenue for slowing, stopping, or reversing a disease that has, up to now, been largely untreatable. Target discovery is the creative science that is foundational to breakthroughs in drug discovery and development and changing outcomes for people diagnosed with ALS in the future.

How we listen

SOURCE: Self-reported by organization

Seeking feedback from people served makes programs more responsive and effective. Here’s how this organization is listening.

done We demonstrated a willingness to learn more by reviewing resources about feedback practice.
done We shared information about our current feedback practices.
  • How is your organization using feedback from the people you serve?

    To identify bright spots and enhance positive service experiences, To inform the development of new programs/projects, To strengthen relationships with the people we serve

  • Which of the following feedback practices does your organization routinely carry out?

    We aim to collect feedback from as many people we serve as possible, We take steps to ensure people feel comfortable being honest with us, We look for patterns in feedback based on people’s interactions with us (e.g., site, frequency of service, etc.), We engage the people who provide feedback in looking for ways we can improve in response, We act on the feedback we receive, We tell the people who gave us feedback how we acted on their feedback

  • What challenges does the organization face when collecting feedback?

    It is difficult to get the people we serve to respond to requests for feedback, The people we serve tell us they find data collection burdensome, Staff find it hard to prioritize feedback collection and review due to lack of time

Financials

Augies Quest To Cure ALS Inc
lock

Unlock financial insights by subscribing to our monthly plan.

Subscribe

Unlock nonprofit financial insights that will help you make more informed decisions. Try our monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights?
Learn more about GuideStar Pro.

Operations

The people, governance practices, and partners that make the organization tick.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

lock

Connect with nonprofit leaders

Subscribe

Build relationships with key people who manage and lead nonprofit organizations with GuideStar Pro. Try a low commitment monthly plan today.

  • Analyze a variety of pre-calculated financial metrics
  • Access beautifully interactive analysis and comparison tools
  • Compare nonprofit financials to similar organizations

Want to see how you can enhance your nonprofit research and unlock more insights? Learn More about GuideStar Pro.

Augies Quest To Cure ALS Inc

Board of directors
as of 06/06/2024
SOURCE: Self-reported by organization
Board chair

Ms. Lynne Nieto

Lynne Nieto

Bert Selva

Shea Homes

Paul Sallaberry

Eric Affeldt

Sherri Medina

HealthBridge

Samuel James Worthington

Newtown Athletic Club

Jon Canarick

North Castle Partners

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes
  • Board performance
    Has the board conducted a formal, written self-assessment of its performance within the past three years? No

Organizational demographics

SOURCE: Self-reported; last updated 6/6/2024

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Female, Not transgender
Sexual orientation
Heterosexual or Straight
Disability status
Person without a disability

Race & ethnicity

Gender identity

Transgender Identity

Sexual orientation

Disability

Equity strategies

Last updated: 02/01/2022

GuideStar partnered with Equity in the Center - an organization that works to shift mindsets, practices, and systems to increase racial equity - to create this section. Learn more

Data
  • We have long-term strategic plans and measurable goals for creating a culture such that one’s race identity has no influence on how they fare within the organization.
Policies and processes
  • We use a vetting process to identify vendors and partners that share our commitment to race equity.
  • We help senior leadership understand how to be inclusive leaders with learning approaches that emphasize reflection, iteration, and adaptability.
  • We engage everyone, from the board to staff levels of the organization, in race equity work and ensure that individuals understand their roles in creating culture such that one’s race identity has no influence on how they fare within the organization.